The Oncolytic Virus Therapy Market growth is driven by the increasing demand for innovative cancer treatments that offer improved outcomes with fewer side effects. Traditional cancer therapies often cause significant toxicity and damage to healthy cells, leading to a need for safer alternatives. Oncolytic virus therapy provides a targeted approach that minimizes harm to normal tissues while effectively attacking cancer cells. This has led to growing interest among healthcare providers and patients.

Additionally, emerging trends such as combination therapies are gaining traction in the market. Oncolytic viruses are being used alongside immunotherapies and chemotherapy to enhance treatment effectiveness. The integration of advanced technologies such as artificial intelligence is also improving the efficiency of drug development and clinical trials. Continuous research and innovation are expected to introduce new therapies, further driving market growth and expanding treatment options.

FAQ

Q1. What drives market growth?
Demand for targeted and less toxic cancer treatments.

Q2. What are key trends?
Combination therapies and advanced research technologies.